Brain death worldwide: accepted fact but no global consensus in diagnostic criteria EFM Wijdicks Neurology 58 (1), 20-25, 2002 | 751 | 2002 |
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 540 | 2019 |
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives RH Swerdlow, JM Burns, SM Khan Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (8 …, 2014 | 472 | 2014 |
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 1-14, 2016 | 464 | 2016 |
The Alzheimer's disease mitochondrial cascade hypothesis RH Swerdlow, JM Burns, SM Khan Journal of Alzheimer's Disease 20 (s2), S265-S279, 2010 | 436 | 2010 |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 429 | 2017 |
Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign JM Burns, RH Swerdlow Archives of neurology 60 (3), 437-440, 2003 | 420 | 2003 |
Cardiorespiratory fitness and brain atrophy in early Alzheimer disease JM Burns, BB Cronk, HS Anderson, JE Donnelly, GP Thomas, A Harsha, ... Neurology 71 (3), 210-216, 2008 | 375 | 2008 |
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease RS Turner, RG Thomas, S Craft, CH Van Dyck, J Mintzer, BA Reynolds, ... Neurology 85 (16), 1383-1391, 2015 | 367 | 2015 |
Progressive posterior cortical dysfunction: a clinicopathologic series JA Renner, JM Burns, CE Hou, DW McKeel, M Storandt, JC Morris Neurology 63 (7), 1175-1180, 2004 | 316 | 2004 |
Reduced lean mass in early Alzheimer disease and its association with brain atrophy JM Burns, DK Johnson, A Watts, RH Swerdlow, WM Brooks Archives of neurology 67 (4), 428-433, 2010 | 252 | 2010 |
Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 225 | 2016 |
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 215 | 2010 |
Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer's disease R Honea, GP Thomas, A Harsha, HS Anderson, JE Donnelly, WM Brooks, ... Alzheimer disease and associated disorders 23 (3), 188, 2009 | 215 | 2009 |
Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study RA Honea, E Vidoni, A Harsha, JM Burns Journal of Alzheimer's disease 18 (3), 553-564, 2009 | 202 | 2009 |
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, L Minthon, ... Neurology 85 (14), 1240-1249, 2015 | 194 | 2015 |
Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease. J McDowd, L Hoffman, E Rozek, KE Lyons, R Pahwa, J Burns, S Kemper Neuropsychology 25 (2), 210, 2011 | 183 | 2011 |
White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease JM Burns, JA Church, DK Johnson, C Xiong, D Marcus, AF Fotenos, ... Archives of neurology 62 (12), 1870-1876, 2005 | 176 | 2005 |
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE S Ayton, NG Faux, AI Bush Nature communications 6 (1), 1-9, 2015 | 158 | 2015 |
In vivo staging of regional amyloid deposition MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ... Neurology 89 (20), 2031-2038, 2017 | 151 | 2017 |